Cargando…
Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy
Introduction: The effects of spinal bulbar muscular atrophy (SBMA) on quality of life (QoL) are not well understood. This study describes symptoms from the patient's perspective and the impact these symptoms have on QoL. Methods: We conducted open‐ended interviews with 21 adult men with genetic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763365/ https://www.ncbi.nlm.nih.gov/pubmed/28877556 http://dx.doi.org/10.1002/mus.25957 |
_version_ | 1783291871905185792 |
---|---|
author | Guber, Robert D. Kokkinis, Angela D. Schindler, Alice B. Bendixen, Roxanna M. Heatwole, Chad R. Fischbeck, Kenneth H. Grunseich, Christopher |
author_facet | Guber, Robert D. Kokkinis, Angela D. Schindler, Alice B. Bendixen, Roxanna M. Heatwole, Chad R. Fischbeck, Kenneth H. Grunseich, Christopher |
author_sort | Guber, Robert D. |
collection | PubMed |
description | Introduction: The effects of spinal bulbar muscular atrophy (SBMA) on quality of life (QoL) are not well understood. This study describes symptoms from the patient's perspective and the impact these symptoms have on QoL. Methods: We conducted open‐ended interviews with 21 adult men with genetically confirmed SBMA. Using a qualitative framework technique, we coded and analyzed interviews to identify symptoms and resulting themes. Results: From these interviews, 729 quotations were extracted. We identified 200 SBMA‐specific symptoms and 20 symptomatic themes. Weakness was mentioned by all interviewees. Symptoms within the domain of mental health and the specific themes of emotional issues and psychological impact were also frequently mentioned. Discussion: Numerous symptoms affect QoL for patients with SBMA. We identified previously unrecognized symptoms that are important to address in enhancing clinical care for patients with SBMA and in developing tools to evaluate efficacy in future clinical trials. Muscle Nerve 57: 40–44, 2018 |
format | Online Article Text |
id | pubmed-5763365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57633652018-01-17 Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy Guber, Robert D. Kokkinis, Angela D. Schindler, Alice B. Bendixen, Roxanna M. Heatwole, Chad R. Fischbeck, Kenneth H. Grunseich, Christopher Muscle Nerve Clinical Research Introduction: The effects of spinal bulbar muscular atrophy (SBMA) on quality of life (QoL) are not well understood. This study describes symptoms from the patient's perspective and the impact these symptoms have on QoL. Methods: We conducted open‐ended interviews with 21 adult men with genetically confirmed SBMA. Using a qualitative framework technique, we coded and analyzed interviews to identify symptoms and resulting themes. Results: From these interviews, 729 quotations were extracted. We identified 200 SBMA‐specific symptoms and 20 symptomatic themes. Weakness was mentioned by all interviewees. Symptoms within the domain of mental health and the specific themes of emotional issues and psychological impact were also frequently mentioned. Discussion: Numerous symptoms affect QoL for patients with SBMA. We identified previously unrecognized symptoms that are important to address in enhancing clinical care for patients with SBMA and in developing tools to evaluate efficacy in future clinical trials. Muscle Nerve 57: 40–44, 2018 John Wiley and Sons Inc. 2017-09-25 2018-01 /pmc/articles/PMC5763365/ /pubmed/28877556 http://dx.doi.org/10.1002/mus.25957 Text en © 2017 The Authors. Muscle & Nerve Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Clinical Research Guber, Robert D. Kokkinis, Angela D. Schindler, Alice B. Bendixen, Roxanna M. Heatwole, Chad R. Fischbeck, Kenneth H. Grunseich, Christopher Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy |
title | Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy |
title_full | Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy |
title_fullStr | Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy |
title_full_unstemmed | Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy |
title_short | Patient‐identified impact of symptoms in spinal and bulbar muscular atrophy |
title_sort | patient‐identified impact of symptoms in spinal and bulbar muscular atrophy |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763365/ https://www.ncbi.nlm.nih.gov/pubmed/28877556 http://dx.doi.org/10.1002/mus.25957 |
work_keys_str_mv | AT guberrobertd patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy AT kokkinisangelad patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy AT schindleraliceb patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy AT bendixenroxannam patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy AT heatwolechadr patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy AT fischbeckkennethh patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy AT grunseichchristopher patientidentifiedimpactofsymptomsinspinalandbulbarmuscularatrophy |